↓ Skip to main content

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter
11 tweeters

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
Published in
Journal for Immunotherapy of Cancer, January 2019
DOI 10.1186/s40425-019-0514-3
Pubmed ID
Authors

Saori Mishima, Akihito Kawazoe, Yoshiaki Nakamura, Akinori Sasaki, Daisuke Kotani, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Toshihiko Doi, Atsushi Ohtsu, Takayuki Yoshino, Takeshi Kuwata, Akihito Tsuji, Kohei Shitara

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 19%
Other 5 9%
Student > Doctoral Student 5 9%
Student > Postgraduate 5 9%
Student > Bachelor 3 6%
Other 10 19%
Unknown 16 30%
Readers by discipline Count As %
Medicine and Dentistry 19 35%
Biochemistry, Genetics and Molecular Biology 7 13%
Mathematics 4 7%
Immunology and Microbiology 3 6%
Computer Science 2 4%
Other 3 6%
Unknown 16 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2020.
All research outputs
#4,855,370
of 19,736,584 outputs
Outputs from Journal for Immunotherapy of Cancer
#959
of 2,286 outputs
Outputs of similar age
#102,356
of 359,831 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 1 outputs
Altmetric has tracked 19,736,584 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,286 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.1. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,831 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them